Xponance Inc. Purchases 560 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Xponance Inc. lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,469 shares of the biotechnology company’s stock after acquiring an additional 560 shares during the quarter. Xponance Inc.’s holdings in Axon Enterprise were worth $9,788,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $40,000. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the third quarter worth $41,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $45,000. Finally, Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $53,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of a number of analyst reports. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $604.67.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,792 shares of company stock worth $1,087,843. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $539.99 on Wednesday. The firm has a market cap of $41.38 billion, a P/E ratio of 139.53, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The business’s 50 day moving average is $592.66 and its 200-day moving average is $539.27.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.